Stockreport

Morphic Presents New Biomarker Data at DDW 2023 Supporting MORF-057 Program in Ulcerative Colitis

Morphic Holding, Inc.  (MORF) 
Last morphic holding, inc. earnings: 11/12 04:24 pm Check Earnings Report
PDF WALTHAM, Mass., May 11, 2023 (GLOBE NEWSWIRE) -- Morphic Therapeutic (NASDAQ: MORF) today announced the presentation of new preclinical data in the MORF-057 IBD develo [Read more]